Free Trial

MDxHealth (MDXH) Competitors

MDxHealth logo
$2.19 -0.02 (-0.90%)
As of 07/3/2025 01:05 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

MDXH vs. TBRG, OM, HCAT, NYXH, SOPH, KRMD, EUDA, AMWL, LUNG, and CCLD

Should you be buying MDxHealth stock or one of its competitors? The main competitors of MDxHealth include TruBridge (TBRG), Outset Medical (OM), Health Catalyst (HCAT), Nyxoah (NYXH), SOPHiA GENETICS (SOPH), KORU Medical Systems (KRMD), EUDA Health (EUDA), American Well (AMWL), Pulmonx (LUNG), and CareCloud (CCLD). These companies are all part of the "medical info sys" industry.

MDxHealth vs. Its Competitors

TruBridge (NASDAQ:TBRG) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends.

TruBridge has higher revenue and earnings than MDxHealth. TruBridge is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TruBridge$339.17M1.01-$19.67M-$1.35-16.93
MDxHealth$90.05M1.15-$38.07M-$1.15-1.90

TruBridge has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500. Comparatively, MDxHealth has a beta of 1.31, indicating that its share price is 31% more volatile than the S&P 500.

TruBridge has a net margin of -5.86% compared to MDxHealth's net margin of -41.02%. TruBridge's return on equity of 0.33% beat MDxHealth's return on equity.

Company Net Margins Return on Equity Return on Assets
TruBridge-5.86% 0.33% 0.14%
MDxHealth -41.02%-492.11%-23.00%

TruBridge presently has a consensus price target of $21.25, indicating a potential downside of 7.02%. MDxHealth has a consensus price target of $6.50, indicating a potential upside of 196.80%. Given MDxHealth's stronger consensus rating and higher possible upside, analysts clearly believe MDxHealth is more favorable than TruBridge.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TruBridge
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
MDxHealth
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, MDxHealth had 4 more articles in the media than TruBridge. MarketBeat recorded 4 mentions for MDxHealth and 0 mentions for TruBridge. TruBridge's average media sentiment score of 0.00 equaled MDxHealth'saverage media sentiment score.

Company Overall Sentiment
TruBridge Neutral
MDxHealth Neutral

88.6% of TruBridge shares are owned by institutional investors. 10.7% of TruBridge shares are owned by insiders. Comparatively, 1.7% of MDxHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

TruBridge and MDxHealth tied by winning 7 of the 14 factors compared between the two stocks.

Get MDxHealth News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDXH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDXH vs. The Competition

MetricMDxHealthMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$103.56M$2.04B$5.56B$9.05B
Dividend YieldN/AN/A5.24%3.99%
P/E Ratio-1.9017.0519.9620.26
Price / Sales1.1515.98419.56119.26
Price / CashN/A55.8726.2128.59
Price / Book7.068.718.035.65
Net Income-$38.07M-$62.39M$3.18B$249.15M
7 Day Performance-4.78%2.58%2.93%3.28%
1 Month Performance5.80%1.47%1.72%3.95%
1 Year Performance-6.41%4.09%34.39%20.98%

MDxHealth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MDXH
MDxHealth
1.5988 of 5 stars
$2.19
-0.9%
$6.50
+196.8%
-6.4%$103.56M$90.05M-1.90300News Coverage
TBRG
TruBridge
1.0356 of 5 stars
$23.42
+0.9%
$21.25
-9.3%
+105.0%$348.54M$339.17M-17.353,200
OM
Outset Medical
1.6562 of 5 stars
$19.21
+0.7%
$27.00
+40.6%
-63.8%$337.96M$113.69M-0.66520High Trading Volume
HCAT
Health Catalyst
4.3729 of 5 stars
$3.77
-1.0%
$8.00
+112.2%
-33.9%$265.18M$306.58M-3.281,500
NYXH
Nyxoah
3.0111 of 5 stars
$7.48
+0.1%
$14.50
+93.9%
-0.7%$254.43M$4.89M-3.51110
SOPH
SOPHiA GENETICS
2.3603 of 5 stars
$3.10
+0.3%
$7.00
+125.8%
-35.0%$206.06M$65.17M-3.10520Positive News
KRMD
KORU Medical Systems
2.2083 of 5 stars
$3.58
-1.4%
$4.50
+25.7%
+43.7%$167.49M$33.65M-32.5580Positive News
High Trading Volume
EUDA
EUDA Health
N/A$3.58
+4.4%
N/A-10.0%$127.45M$4.01M0.002Gap Up
AMWL
American Well
3.4968 of 5 stars
$8.89
+12.0%
$9.67
+8.7%
+36.6%$123.94M$254.36M-0.871,040
LUNG
Pulmonx
3.008 of 5 stars
$2.59
-0.4%
$11.53
+345.0%
-57.2%$104.67M$83.79M-1.80250News Coverage
CCLD
CareCloud
2.4095 of 5 stars
$2.36
-2.1%
$2.50
+5.9%
+13.2%$101.99M$110.84M-10.733,650News Coverage
Analyst Downgrade
Gap Up

Related Companies and Tools


This page (NASDAQ:MDXH) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners